Kantar Health Names Goosey Senior Director, Advanced Methods in UK
pharmafile | April 18, 2012 | News story | Business Services | Kantar Health, Richard Goosey, clinical statistics, market research
NEW YORK, April 18, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has named Richard Goosey Senior Director of Advanced Methods for Kantar Health UK. Mr. Goosey has 30 years of consultancy experience in marketing sciences and advanced analytics on both the agency and client side covering both healthcare and consumer markets.
Mr. Goosey joins Kantar Health from Roche UK, where he specialized in business planning and forecasting in support of the Oncology HER2 Franchise. Prior to Roche he was Head of Business Intelligence and Commercial Planning for Lundbeck Pharmaceuticals UK, specializing in psychiatry and neurology, where he provided business support services across the brand portfolio. Mr. Goosey is a Fellow of the Market Research Society (MRS) and is currently the Chief Examiner for the MRS Diploma in Analyzing and Interpreting Quantitative Data. He is a Fellow of the Royal Statistical Society and has served on the Social Statistics Committee.
Mr. Goosey is a chartered statistician with a first degree in Applied Statistics and Master’s degree in Mathematical Techniques of Statistics and Operational Research from London University.
“We are delighted to welcome Richard into the Kantar Health family,” says Jim Needell, Managing Director, UK. “His vast experience in designing complex studies and consulting with senior clients continues our evolution as a business to better meet the changing needs of our clients.”
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With offices in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
Contact Information
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at paula.paradise@kantarhealth.com or +1-484-442-1431.
Related Content
Kantar Health Launches Global Health and Wellness Quarterly Update
The inaugural issue of Kantar Health’s Global Health and Wellness Update is now available. This …
Kantar Health Names Werner Guminski CEO, Commercial Strategy
Kantar Health Names Werner Guminski CEO, Commercial StrategyNEW YORK, July 8, 2011—Kantar Health, a leading …
A bigger conversation: taking market research online
The debate around pharma’s use of digital media has tended to focus on building relationships …
